about
Liver transplantation for homozygous familial hypercholesterolaemiaIntrapulmonary shunting in the biliary atresia/polysplenia syndrome: reversal after liver transplantation.Ventilatory strategy during liver transplantation: implications for near-infrared spectroscopy-determined frontal lobe oxygenationLiver transplantation in the Nordic countries - An intention to treat and post-transplant analysis from The Nordic Liver Transplant Registry 1982-2013.Clinical Application of Variation in Replication Kinetics During Episodes of Post-transplant Cytomegalovirus Infections.Outbreak of pneumocystis pneumonia in renal and liver transplant patients caused by genotypically distinct strains of Pneumocystis jiroveciiThe clinical utility of FDG PET/CT among solid organ transplant recipients suspected of malignancy or infection.Generic tacrolimus in solid organ transplantation.Risk of infectious diseases among first-degree relatives of transplant recipients who develop CMV infection: is the infectious phenotype inheritable?Differences in long-term survival among liver transplant recipients and the general population: a population-based Nordic study.Serologic and molecular biomarkers for recurrence of hepatocellular carcinoma after liver transplantation: A systematic review and meta-analysis.Impaired intention-to-treat survival after listing for liver transplantation in children with biliary atresia compared to other chronic liver diseases: 20 years' experience from the Nordic countries.Risk factors for metabolic syndrome after liver transplantation: A systematic review and meta-analysis.Remote ischemic preconditioning of transplant recipients to reduce graft ischemia and reperfusion injuries: A systematic review.MELD score measured day 10 after orthotopic liver transplantation predicts death and re-transplantation within the first year.Transplantation With Livers From Deceased Donors Older Than 75 Years.High-volume plasma exchange in patients with acute liver failure: An open randomised controlled trial.The time course of development and impact from viral resistance against ganciclovir in cytomegalovirus infection.The effect of selective bowel decontamination on the pharmacokinetics of mycophenolate mofetil in liver transplant recipients.The effect of hepatectomy on glucose homeostasis in pig and in man.[Partial orthotopic liver transplantation]Idiopathic extensive peliosis hepatis treated with liver transplantation.[Follicular dendritic cell sarcoma].Clostridium difficile Infection in Solid Organ and Haematopoietic Stem Cell Transplant Recipients.Risk factors and prognosis for recurrent primary sclerosing cholangitis after liver transplantation: a Nordic Multicentre Study.The use of reduced-size liver grafts in elective nonurgent recipients.Locoregional treatments before liver transplantation for hepatocellular carcinoma: A study from the European Liver Transplant Registry.[Reconstruction of major bile duct injuries after laparoscopic cholecystectomy].The Danish liver transplantation program and patients with serious acetaminophen intoxication.Interference of cerebral near-infrared oximetry in patients with icterus.Prevention of hypophosphatemia during postoperative routine glucose administration.Induction of immunosuppression by microemulsion cyclosporine in liver transplantation.Factors associated with the development of cytomegalovirus infection following solid organ transplantation.Cytomegalovirus (CMV) Disease Despite Weekly Preemptive CMV Strategy for Recipients of Solid Organ and Hematopoietic Stem Cell Transplantation.Endoscopic Ultrasound Duplex Scanning for Measurement of Portal Venous Flow: Validation against Transit Time Ultrasound Flowmetry in PigsRegarding: Humar et al. The Efficacy and Safety of 200 Days Valganciclovir Cytomegalovirus Prophylaxis in High-Risk Kidney Transplant Recipients. Am J Transplant 2010;10:1228-1237Risk markers for later cardiovascular diseases in liver-transplanted children and adolescentsHepatitis C impairs survival following liver transplantation irrespective of concomitant hepatocellular carcinomaIs a 3-day limit for highly urgent liver transplantation for fulminant hepatic failure appropriate, and is the diagnosis in some cases incorrect?[Small intestine transplant for intestinal failure in children]
P50
Q24553311-64B83A34-581A-48DB-A07A-63A09498F93CQ33624709-7F116E6C-75D1-42C3-BD95-1BC7614EF203Q34080644-3DFDE13A-E511-4922-B9E2-443A5BC84858Q35805172-78795C3F-0F62-4631-8C67-DD875ACD2824Q35947524-797CDD95-C3D1-43D4-98DE-937CEB24FE6DQ37305589-704746AF-7D43-4585-8E7A-1271BEFEABB4Q37614753-67676A2C-E48C-4F2E-A95D-2CB8ABC076E0Q38205921-5CF30930-6AA9-4AD0-8034-FB3A328FBC4AQ38399221-ADA202C2-122F-4A91-B95F-6E76FF22B2F7Q38418542-1A3815CD-52C8-4282-B171-2E952ADA9327Q38818641-4403AEB7-7BE7-4AF0-8ABD-384E8EFA9E64Q39106252-8B85D60F-23D5-461A-B275-85EB40846F9CQ39304271-B8AFE9E2-8DE5-4ED7-AE56-88BCE2C92DCEQ39388750-F6BF1837-DB40-4617-B72C-92F3C0B08406Q40693127-486FD003-E444-4C01-B9ED-B4EF6854F53CQ41018560-79440E7B-C371-42AB-857B-B8207F2BD439Q41435123-E6AD6775-9F67-45B6-B91D-52B259BBD4DAQ42280383-E62A44BF-032A-45F0-BE84-A5B5822E54FBQ43710500-57AA9C64-851F-4328-9C85-C0CAFE7A7255Q43862549-37B29FE0-6530-45C1-9A5E-AB8B69332A39Q44539141-C31C592E-E5C5-472F-8E82-D37A3EC5FD98Q45153969-83EC640C-7725-4276-9EFB-5AF11F8E7CAFQ46521776-70C49EB4-8B9D-49EC-A347-C17CCB96B0ADQ47151943-DF0398C2-B253-4E0F-9250-00D7C3C17946Q47208750-C4782341-0967-4913-81E9-CF9CCB4A06F2Q47374542-6CAB9E98-72C0-4237-A462-46B40D90382BQ49586454-CF4097C3-18F8-4B33-A54D-B12F113F63BDQ50170863-C40A35F5-7FA1-481A-BABB-584054ECB43DQ50559081-90E38564-5232-4920-9E24-8C3A207D1321Q51421153-3C231946-50B1-49D8-85C4-84E3C3FA2E3FQ51660757-BD78EFA1-7DBE-4A39-8E1B-1DC7873C5C80Q53890423-DA8BEEB3-1106-481D-A768-AB6E7A2FDDCEQ54388614-746DA76E-9150-487B-8709-FD59D96C4685Q55074501-01E021B2-A401-4D35-B37A-6F7AC3A885FAQ57419831-58EAB073-8530-4C5B-9A1C-6631D3FD10D8Q57877095-F39F032A-F9EA-4358-AC97-16795C6D4124Q58589788-BCD86BAE-B5FA-49A5-A58C-844C755268BEQ59257886-611EF99F-6C8A-4D5A-8E21-FE9C6C688BC6Q59257972-4E9F4B29-2EC5-4F3D-95D4-0D79927DB4D8Q60494246-D09F7ABE-19DE-4B1F-BC90-557D8A5DCEDA
P50
description
onderzoeker
@nl
researcher
@en
հետազոտող
@hy
name
A Rasmussen
@ast
A Rasmussen
@en
A Rasmussen
@es
A Rasmussen
@nl
type
label
A Rasmussen
@ast
A Rasmussen
@en
A Rasmussen
@es
A Rasmussen
@nl
prefLabel
A Rasmussen
@ast
A Rasmussen
@en
A Rasmussen
@es
A Rasmussen
@nl
P106
P108
P1153
7102424069
P31
P496
0000-0002-9550-4767